Posted on June 21, 2021 by julian

An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942) – Full Text View – ClinicalTrials.gov